{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:59:45Z","timestamp":1760162385176,"version":"3.30.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"DOI":"10.7759\/cureus.75221","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:34:41Z","timestamp":1733499281000},"source":"Crossref","is-referenced-by-count":1,"title":["Role of Ceftazidime-Avibactam in Urinary Tract Infections Caused by Carbapenem-Resistant Enterobacterales"],"prefix":"10.7759","author":[{"given":"Shipra","family":"Dobhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manodeep","family":"Sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyotsana","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupam","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhilash","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumya","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Urinary tract infections, pyelonephritis, and prostatitis","author":"Gupta K","year":"2022","unstructured":"Gupta K, Trautner BW . Urinary tract infections, pyelonephritis, and prostatitis. Harrison\u2019s Principles of Internal Medicine. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J (ed): McGraw Hill\/Medical, New ; 2022. 1:1070-8."},{"key":"ref2","article-title":"Urinary tract infections in adults","volume":"59","author":"Orenstein R","year":"1999","unstructured":"Orenstein R, Wong ES . Urinary tract infections in adults. Am Fam Physician. 1999, 59:1225-37.","journal-title":"Am Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/2049936115621709","article-title":"Carbapenem resistance: overview of the problem and future perspectives","volume":"3","author":"Meletis G","year":"2016","unstructured":"Meletis G. Carbapenem resistance: overview of the problem and future perspectives. Ther Adv Infect Dis. 2016, 3:15-21. 10.1177\/2049936115621709","journal-title":"Ther Adv Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28283","article-title":"Early and appropriate use of ceftazidime-avibactam in the management of multidrug-resistant gram-negative bacterial infections in the Indian scenario","volume":"14","author":"Swaminathan S","year":"2022","unstructured":"Swaminathan S, Routray A, Mane A. Early and appropriate use of ceftazidime-avibactam in the management of multidrug-resistant gram-negative bacterial infections in the Indian scenario. Cureus. 2022, 14:e28283. 10.7759\/cureus.28283","journal-title":"Cureus"},{"key":"ref5","unstructured":"PASS 2021 Power. (2021). Accessed. December 1, 2021: https:\/\/www.ncss.com\/software\/pass\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton TM","year":"2010","unstructured":"Hooton TM, Bradley SF, Cardenas DD, et al.. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010, 50:625-63. 10.1086\/650482","journal-title":"Clin Infect Dis"},{"key":"ref7","article-title":"CLSI Performance Standards for Antimicrobial Susceptibility Testing M100","author":"Clinical and Laboratory Standards Institute","year":"2022","unstructured":"Clinical and Laboratory Standards Institute. CLSI Performance Standards for Antimicrobial Susceptibility Testing M100.  Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA; 2022."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.12.006","article-title":"Susceptibility testing for aztreonam plus ceftazidime\/avibactam combination: a general guidance for clinical microbiology laboratories in India","volume":"40","author":"Bakthavatchalam YD","year":"2022","unstructured":"Bakthavatchalam YD, Walia K, Veeraraghavan B. Susceptibility testing for aztreonam plus ceftazidime\/avibactam combination: a general guidance for clinical microbiology laboratories in India. Indian J Med Microbiol. 2022, 40:3-6. 10.1016\/j.ijmmb.2021.12.006","journal-title":"Indian J Med Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant Gram-negative bacterial infections","volume":"69","author":"Doi Y","year":"2019","unstructured":"Doi Y. Treatment options for carbapenem-resistant Gram-negative bacterial infections. Clin Infect Dis. 2019, 69:S565-75. 10.1093\/cid\/ciz830","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2019.04.011","article-title":"Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat","volume":"36","author":"Lutgring JD","year":"2019","unstructured":"Lutgring JD. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat. Semin Diagn Pathol. 2019, 36:182-6. 10.1053\/j.semdp.2019.04.011","journal-title":"Semin Diagn Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijmm.IJMM_17_415","article-title":"Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: study for monitoring antimicrobial resistance trend report","volume":"36","author":"Veeraraghavan B","year":"2018","unstructured":"Veeraraghavan B, Jesudason MR, Prakasah JA, et al.. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: study for monitoring antimicrobial resistance trend report. Indian J Med Microbiol. 2018, 36:32-6. 10.4103\/ijmm.IJMM_17_415","journal-title":"Indian J Med Microbiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S250384","article-title":"Analysis of susceptibilities of carbapenem-resistant Enterobacterales to colistin in intra-abdominal, respiratory and urinary tract infections from 2015 to 2017","volume":"13","author":"Zhang H","year":"2020","unstructured":"Zhang H, Zhang J, Kang Y, Yang Q, Xu Y. Analysis of susceptibilities of carbapenem-resistant Enterobacterales to colistin in intra-abdominal, respiratory and urinary tract infections from 2015 to 2017. Infect Drug Resist. 2020, 13:1937-48. 10.2147\/IDR.S250384","journal-title":"Infect Drug Resist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.036483-0","article-title":"Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China","volume":"61","author":"Hu F","year":"2012","unstructured":"Hu F, Chen S, Xu X, Guo Y, Liu Y, Zhu D, Zhang Y. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J Med Microbiol. 2012, 61:132-6. 10.1099\/jmm.0.036483-0","journal-title":"J Med Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06229-x","article-title":"Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia","volume":"21","author":"Shields RK","year":"2021","unstructured":"Shields RK, Zhou Y, Kanakamedala H, Cai B. Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia. BMC Infect Dis. 2021, 21:572. 10.1186\/s12879-021-06229-x","journal-title":"BMC Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2021.0106","article-title":"Molecular characterization of carbapenem-resistant Enterobacterales collected in the United States","volume":"28","author":"Karlsson M","year":"2022","unstructured":"Karlsson M, Lutgring JD, Ansari U, et al.. Molecular characterization of carbapenem-resistant Enterobacterales collected in the United States. Microb Drug Resist. 2022, 28:389-97. 10.1089\/mdr.2021.0106","journal-title":"Microb Drug Resist"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.12480","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013","volume":"314","author":"Guh AY","year":"2015","unstructured":"Guh AY, Bulens SN, Mu Y, et al.. Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013. JAMA. 2015, 314:1479-87. 10.1001\/jama.2015.12480","journal-title":"JAMA"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_2086_17","article-title":"Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections","volume":"149","author":"Amladi AU","year":"2019","unstructured":"Amladi AU, Abirami B, Devi SM, et al.. Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections. Indian J Med Res. 2019, 149:185-91. 10.4103\/ijmr.IJMR_2086_17","journal-title":"Indian J Med Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2021.05.008","article-title":"Genotypic characterization of carbapenem resistant Enterobacterales in clinical isolates from western Maharashtra","volume":"39","author":"Giri S","year":"2021","unstructured":"Giri S, Karade S, Sen S. Genotypic characterization of carbapenem resistant Enterobacterales in clinical isolates from western Maharashtra. Indian J Med Microbiol. 2021, 39:500-3. 10.1016\/j.ijmmb.2021.05.008","journal-title":"Indian J Med Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.01.011","article-title":"Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain","volume":"51","author":"Garc\u00eda-Castillo M","year":"2018","unstructured":"Garc\u00eda-Castillo M, Garc\u00eda-Fern\u00e1ndez S, G\u00f3mez-Gil R, et al.. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain. Int J Antimicrob Agents. 2018, 51:511-5. 10.1016\/j.ijantimicag.2018.01.011","journal-title":"Int J Antimicrob Agents"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/jacamr\/dlad137","article-title":"Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testing","volume":"6","author":"Mushtaq A","year":"2024","unstructured":"Mushtaq A, Alburquerque B, Chung M, et al.. Clinical, microbiological and genomic characterization of Gram-negative bacteria with dual carbapenemases as identified by rapid molecular testing. JAC Antimicrob Resist. 2024, 6:dlad137. 10.1093\/jacamr\/dlad137","journal-title":"JAC Antimicrob Resist"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw239","article-title":"Spotlight on ceftazidime\/avibactam: a new option for MDR Gram-negative infections","volume":"71","author":"Falcone M","year":"2016","unstructured":"Falcone M, Paterson D. Spotlight on ceftazidime\/avibactam: a new option for MDR Gram-negative infections. J Antimicrob Chemother. 2016, 71:2713-22. 10.1093\/jac\/dkw239","journal-title":"J Antimicrob Chemother"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03042-15","article-title":"In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible Enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014)","volume":"60","author":"de Jonge BL","year":"2016","unstructured":"de Jonge BL, Karlowsky JA, Kazmierczak KM, Biedenbach DJ, Sahm DF, Nichols WW. In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible Enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014). Antimicrob Agents Chemother. 2016, 60:3163-9. 10.1128\/AAC.03042-15","journal-title":"Antimicrob Agents Chemother"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0902-x","article-title":"Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections","volume":"78","author":"Shirley M","year":"2018","unstructured":"Shirley M. Ceftazidime-avibactam: a review in the treatment of serious gram-negative bacterial infections. Drugs. 2018, 78:675-92. 10.1007\/s40265-018-0902-x","journal-title":"Drugs"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy KK","year":"2010","unstructured":"Kumarasamy KK, Toleman MA, Walsh TR, et al.. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis. 2010, 10:597-602. 10.1016\/S1473-3099(10)70143-2","journal-title":"Lancet Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10081012","article-title":"The revival of aztreonam in combination with avibactam against metallo-\u03b2-lactamase-producing gram-negatives: a systematic review of in vitro studies and clinical cases","volume":"10","author":"Mauri C","year":"2021","unstructured":"Mauri C, Maraolo AE, Di Bella S, Luzzaro F, Principe L. The revival of aztreonam in combination with avibactam against metallo-\u03b2-lactamase-producing gram-negatives: a systematic review of in vitro studies and clinical cases. Antibiotics (Basel). 2021, 10:10.3390\/antibiotics10081012","journal-title":"Antibiotics (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00751-22","article-title":"Ceftazidime-avibactam plus aztreonam for the treatment of infections by VIM-type-producing gram-negative bacteria","volume":"66","author":"Sempere A","year":"2022","unstructured":"Sempere A, Vi\u00f1ado B, Los-Arcos I, et al.. Ceftazidime-avibactam plus aztreonam for the treatment of infections by VIM-type-producing gram-negative bacteria. Antimicrob Agents Chemother. 2022, 66:e0075122. 10.1128\/aac.00751-22","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing Enterobacterales","volume":"72","author":"Falcone M","year":"2021","unstructured":"Falcone M, Daikos GL, Tiseo G, et al.. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing Enterobacterales. Clin Infect Dis. 2021, 72:1871-8. 10.1093\/cid\/ciaa586","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/306860-role-of-ceftazidime-avibactam-in-urinary-tract-infections-caused-by-carbapenem-resistant-enterobacterales","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T15:34:44Z","timestamp":1733499284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/306860-role-of-ceftazidime-avibactam-in-urinary-tract-infections-caused-by-carbapenem-resistant-enterobacterales"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.75221","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}